CENTENE: Completes Acquisition of PANTHERx Rare Pharmacy (PANTHERx)
Centene Corporation (NYSE: CNC) announced that it has completed its acquisition of PANTHERx, one of the largest and fastest-growing specialty pharmacies in the United States specializing in orphan drugs and treating rare diseases. Read More »